Regulation of endometrial cancer cell growth by luteinizing hormone (LH) and follicle stimulating hormone (FSH)
Authors:
Open Access
- 1 December 2000
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 83 (12) , 1730-1734
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- High affinity binding and direct antiproliferative effects of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell lines.The Journal of Clinical Endocrinology & Metabolism, 1993
- Increased bioactive luteinizing hormone levels in postmenopausal women with endometrial cancerAmerican Journal of Obstetrics and Gynecology, 1992
- Evidence for dual coupling of the murine luteinizing hormone receptor to adenylyl cyclase and phosphoinositide breakdown and Ca2+ mobilization. Studies with the cloned murine luteinizing hormone receptor expressed in L cells.Journal of Biological Chemistry, 1992
- A new treatment for endometrial cancer with gonadotrophin releasing‐hormone analogueBJOG: An International Journal of Obstetrics & Gynaecology, 1991
- Suppression of Postmenopausal Ovarian Steroidogenesis With the Luteinizing Hormone-Releasing Hormone Agonist Goserelin*The Journal of Clinical Endocrinology & Metabolism, 1988
- Molecular structure of the human cytoplasmic beta-actin gene: interspecies homology of sequences in the introns.Proceedings of the National Academy of Sciences, 1985
- [Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors].1985
- Cell Lines Derived from Human Ovarian Carcinomas: Growth Stimulation by Gonadotropic and Steroid Hormones23JNCI: Journal of the National Cancer Institute, 1983
- A simple and sensitive saturation assay method for the measurement of adenosine 3′:5′-cyclic monophosphateBiochemical Journal, 1971
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951